
Arcutis Biotherapeutics Inc is a biotechnology business based in the US. Arcutis Biotherapeutics Inc shares (ARQT) are listed on the NASDAQ and all prices are listed in US Dollars. Arcutis Biotherapeutics Inc employs 147 staff and has a trailing 12-month revenue of around $725,000.
How to buy Arcutis Biotherapeutics Inc stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – ARQT. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Arcutis Biotherapeutics Inc stock price (NASDAQ: ARQT)
Use our graph to track the performance of ARQT stocks over time.Arcutis Biotherapeutics Inc shares at a glance
Latest market close | $16.56 |
---|---|
52-week range | $12.81 - $27.40 |
50-day moving average | $16.25 |
200-day moving average | $19.81 |
Wall St. target price | $55.33 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-4.67 |
Buy Arcutis Biotherapeutics Inc stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Arcutis Biotherapeutics Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Arcutis Biotherapeutics Inc price performance over time
Historical closes compared with the close of $16.56 from 2023-01-27
1 week (2023-01-23) | 1.47% |
---|---|
1 month (2022-12-30) | 11.89% |
3 months (2022-10-28) | -5.37% |
6 months (2022-07-29) | -31.74% |
1 year (2022-01-28) | 12.88% |
---|---|
2 years (2021-01-29) | -39.32% |
3 years (2020-01-26) | N/A |
5 years (2018-01-26) | N/A |
Arcutis Biotherapeutics Inc financials
Revenue TTM | $725,000 |
---|---|
Gross profit TTM | $0 |
Return on assets TTM | -42.48% |
Return on equity TTM | -98.07% |
Profit margin | 0% |
Book value | $4.45 |
Market capitalisation | $977.3 million |
TTM: trailing 12 months
Arcutis Biotherapeutics Inc share dividends
We're not expecting Arcutis Biotherapeutics Inc to pay a dividend over the next 12 months.
Arcutis Biotherapeutics Inc share price volatility
Over the last 12 months, Arcutis Biotherapeutics Inc's shares have ranged in value from as little as $12.81 up to $27.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Arcutis Biotherapeutics Inc's is 0.48. This would suggest that Arcutis Biotherapeutics Inc's shares are less volatile than average (for this exchange).
Arcutis Biotherapeutics Inc overview
Arcutis Biotherapeutics, Inc. , a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp psoriasis; ARQ-252, a selective topical janus kinase type 1 inhibitor for hand eczema and vitiligo; and ARQ-255, a topical formulation of ARQ-252 designed to reach deeper into the skin in order to treat alopecia areata. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019.
Arcutis Biotherapeutics Inc in the news
Arcutis' Flagship Psoriasis Treatment Shows Sustained Efficacy, Clearance For Median Of 10 Months
Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis
Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis
Frequently asked questions
What percentage of Arcutis Biotherapeutics Inc is owned by insiders or institutions?Currently 3.203% of Arcutis Biotherapeutics Inc shares are held by insiders and 99.148% by institutions. How many people work for Arcutis Biotherapeutics Inc?
Latest data suggests 147 work at Arcutis Biotherapeutics Inc. When does the fiscal year end for Arcutis Biotherapeutics Inc?
Arcutis Biotherapeutics Inc's fiscal year ends in December. Where is Arcutis Biotherapeutics Inc based?
Arcutis Biotherapeutics Inc's address is: 3027 Townsgate Road, Westlake Village, CA, United States, 91361 What is Arcutis Biotherapeutics Inc's ISIN number?
Arcutis Biotherapeutics Inc's international securities identification number is: US03969K1088 What is Arcutis Biotherapeutics Inc's CUSIP number?
Arcutis Biotherapeutics Inc's Committee on Uniform Securities Identification Procedures number is: 03969K108
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert